Oric Pharmaceuticals Financials
| ORIC Stock | USD 10.56 0.15 1.40% |
Please note, the presentation of Oric Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oric Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Oric Pharmaceuticals' management manipulating its earnings.
Oric Pharmaceuticals Stock Summary
Oric Pharmaceuticals competes with Amylyx Pharmaceuticals, Relay Therapeutics, Precigen, Nektar Therapeutics, and Inhibrx Biosciences. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Oric Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US68622P1093 |
| Business Address | 240 East Grand |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.oricpharma.com |
| Phone | 650 388 5600 |
| Currency | USD - US Dollar |
Oric Pharmaceuticals Key Financial Ratios
Oric Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oric Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oric Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oric Pharmaceuticals competition to find correlations between indicators driving Oric Pharmaceuticals's intrinsic value. More Info.Oric Pharmaceuticals is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oric Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Oric Pharmaceuticals Financials
What exactly are Oric Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Oric Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Oric Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Oric Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Oric Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Oric Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Oric Pharmaceuticals February 10, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oric Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oric Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oric Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oric Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oric Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 20.28 | |||
| Value At Risk | (6.13) | |||
| Potential Upside | 8.28 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |